[Premature ovarian insufficiency induced by alkylating agents (author's transl)]. 1982

A Güitrón, and G Martínez, and G Forsbach, and M Muñoz, and G Joffre, and P Galache, and S Hernández-Ayup

UI MeSH Term Description Entries
D007247 Infertility, Female Diminished or absent ability of a female to achieve conception. Sterility, Female,Sterility, Postpartum,Sub-Fertility, Female,Subfertility, Female,Female Infertility,Female Sterility,Female Sub-Fertility,Female Subfertility,Postpartum Sterility,Sub Fertility, Female
D010050 Ovarian Function Tests Methods used for assessment of ovarian function. Function Test, Ovarian,Function Tests, Ovarian,Ovarian Function Test,Test, Ovarian Function,Tests, Ovarian Function
D002066 Busulfan An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. Busulphan,Busulfan Wellcome,Busulfex,Glyzophrol,Myelosan,Mylecytan,Myleran,Myléran,n-Butane-1,3-di(methylsulfonate),Wellcome, Busulfan
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D006080 Ovarian Follicle An OOCYTE-containing structure in the cortex of the OVARY. The oocyte is enclosed by a layer of GRANULOSA CELLS providing a nourishing microenvironment (FOLLICULAR FLUID). The number and size of follicles vary depending on the age and reproductive state of the female. The growing follicles are divided into five stages: primary, secondary, tertiary, Graafian, and atretic. Follicular growth and steroidogenesis depend on the presence of GONADOTROPINS. Graafian Follicle,Atretic Follicle,Ovarian Follicles,Atretic Follicles,Follicle, Atretic,Follicle, Graafian,Follicle, Ovarian,Follicles, Atretic,Follicles, Graafian,Follicles, Ovarian,Graafian Follicles
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000477 Alkylating Agents Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. Alkylating Agent,Alkylator,Alkylators,Agent, Alkylating,Agents, Alkylating

Related Publications

A Güitrón, and G Martínez, and G Forsbach, and M Muñoz, and G Joffre, and P Galache, and S Hernández-Ayup
March 2023, BMC pregnancy and childbirth,
A Güitrón, and G Martínez, and G Forsbach, and M Muñoz, and G Joffre, and P Galache, and S Hernández-Ayup
January 1981, Journal de gynecologie, obstetrique et biologie de la reproduction,
A Güitrón, and G Martínez, and G Forsbach, and M Muñoz, and G Joffre, and P Galache, and S Hernández-Ayup
September 1975, Deutsche medizinische Wochenschrift (1946),
A Güitrón, and G Martínez, and G Forsbach, and M Muñoz, and G Joffre, and P Galache, and S Hernández-Ayup
May 2022, Best practice & research. Clinical obstetrics & gynaecology,
A Güitrón, and G Martínez, and G Forsbach, and M Muñoz, and G Joffre, and P Galache, and S Hernández-Ayup
August 2022, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
A Güitrón, and G Martínez, and G Forsbach, and M Muñoz, and G Joffre, and P Galache, and S Hernández-Ayup
February 2023, Current opinion in endocrine and metabolic research,
A Güitrón, and G Martínez, and G Forsbach, and M Muñoz, and G Joffre, and P Galache, and S Hernández-Ayup
March 2024, BMJ (Clinical research ed.),
A Güitrón, and G Martínez, and G Forsbach, and M Muñoz, and G Joffre, and P Galache, and S Hernández-Ayup
June 1999, La Revue du praticien,
A Güitrón, and G Martínez, and G Forsbach, and M Muñoz, and G Joffre, and P Galache, and S Hernández-Ayup
January 2024, Best practice & research. Clinical endocrinology & metabolism,
A Güitrón, and G Martínez, and G Forsbach, and M Muñoz, and G Joffre, and P Galache, and S Hernández-Ayup
February 2022, Clinical and translational medicine,
Copied contents to your clipboard!